日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Latest News

Pharmaceutical enterprises making innovation faster and more relevant

By He Wei in Shanghai | China Daily | Updated: 2020-07-23 11:43
Share
Share - WeChat
Visitors at the exhibition area of French pharmaceutical giant Sanofi during the second China International Import Expo in Shanghai on Nov 10, 2019. [Photo/Xinhua]

Global pharmaceutical enterprises are looking to boost business operations in China in a bid to make innovation faster and more relevant to the market.

Business executives attribute the upbeat prospects in China to a thriving digital landscape, strong on-the-ground demand for innovation as well as government efforts to cut red tape and encourage technological breakthroughs.

In July, German science and technology conglomerate Merck opened its M Lab Collaboration Center in Shanghai-an in-house facility that fosters new drug development and offers customized solutions from services to training.

Albeit being the ninth such hub worldwide, the one-stop, technology and training center houses 13 labs and claims to be the biggest of its kind for Merck. It boasts four new functionalities including supporting food and beverage security-related inspections as well as environmental industries that are exclusive to the China market.

"The M Lab means faster turnaround, lowered costs as no travel out of China is needed, access to a vast network of biologics and bio-development experts within Merck and enhanced customer convenience," said Steve Vermant, managing director of Merck Life Science China.

For instance, in a dedicated research lab into proteins-the fundamental building block of life sciences-the company provides solutions from protein preparation and analysis to a number of relevant research tools. These stand to provide customers in China with hands-on training and support them on method optimization and application extension.

The existing global network of M Labs has reaped gains across the value chain during the ongoing COVID-19 pandemic, said Ian Carmichael, vice-president and head of bio processing at Merck Life Science China.

"Some of the candidates for drugs or vaccines have been able to accelerate to commercialization because of the work that was done between Merck and the customers in the past. We can go from labs to clinical trials," Carmichael said.

1 2 Next   >>|

Today's Top News

Editor's picks

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 人人99 | 成年网站在线播放 | 狠狠操电影 | 国产色综合天天综合网 | 日韩精品hd| 久久精品国产一区 | 国产网站在线播放 | 91久久精品国产一区二区 | 国内精品伊人久久久影视 | 亚洲高清在线看 | 亚洲综合在线视频 | 亚洲欧洲视频 | 欧美国产日韩在线观看 | 精品久久不卡 | 黄色a视频 | 最新高清无码专区 | 免费视频二区 | 在线不卡一区 | 草久网| 亚洲人成网站在线在线 | www.91在线| 日韩hd| 国产东北普通话对白 | 新91| 一区二区免费视频观看 | 精品九九九 | 欧美在线看 | www.男插女b免费视频 | 精品国产一区二区三区四 | 亚洲一区中文字幕在线观看 | 高清毛片免费看 | 日本欧美一区二区三区不卡视频 | 国内精品伊人久久久影视 | aaa毛片在线 | 国产免费小视频在线观看 | 国产资源网站 | 日韩在线免费视频观看 | 成人在线小视频 | 偷拍做爰吃奶视频免费看 | 欧美区在线 | 大伊香蕉在线精品不卡视频 |